{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Martinez-Alonso E"],"funding":["Instituto de Salud Carlos III","Ministerio de Economía, Industria y Competitividad, Gobierno de España"],"pagination":["E291"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7222207"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["9(4)"],"pubmed_abstract":["Nitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scavengers, which are two important issues in hypoxia-induced oxidative stress and cell death in brain ischemia. Consequently, nitrones have been proposed as therapeutic agents in acute ischemic stroke (AIS). In this paper, we update the biological and pharmacological characterization of ISQ-201, a previously identified cholesteronitrone hybrid with antioxidant and neuroprotective activity. This study characterizes ISQ-201 as a neuroprotective agent against the hypoxia-induced ischemic injury. Transitory four-vessel occlusion and middle cerebral artery occlusion (tMCAO) were used to induce cerebral ischemia. Functional outcomes were determined using neurofunctional tests. Infarct area, neuronal "],"journal":["Antioxidants (Basel, Switzerland)"],"pubmed_title":["Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke."],"pmcid":["PMC7222207"],"funding_grant_id":["CTQ2016-81797-REDC","CTQ2016-78205-P","SAF2015-65586-R","RD16/0019/0006","PI18/00255"],"pubmed_authors":["Alcazar A","Chioua M","Escobar-Peso A","Fernandez I","Montoya JJ","Montaner J","Martinez-Alonso E","Gonzalo-Gobernado R","Marco-Contelles J","Ayuso MI"],"additional_accession":[]},"is_claimable":false,"name":"Characterization of a CholesteroNitrone (ISQ-201), a Novel Drug Candidate for the Treatment of Ischemic Stroke.","description":"Nitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scavengers, which are two important issues in hypoxia-induced oxidative stress and cell death in brain ischemia. Consequently, nitrones have been proposed as therapeutic agents in acute ischemic stroke (AIS). In this paper, we update the biological and pharmacological characterization of ISQ-201, a previously identified cholesteronitrone hybrid with antioxidant and neuroprotective activity. This study characterizes ISQ-201 as a neuroprotective agent against the hypoxia-induced ischemic injury. Transitory four-vessel occlusion and middle cerebral artery occlusion (tMCAO) were used to induce cerebral ischemia. Functional outcomes were determined using neurofunctional tests. Infarct area, neuronal ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Mar","modification":"2026-05-07T11:59:19.001Z","creation":"2020-06-01T07:04:24Z"},"accession":"S-EPMC7222207","cross_references":{"pubmed":["32244303"],"doi":["10.3390/antiox9040291"]}}